Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

Mise à jour : Il y a 4 ans
Référence : NCT00227305

Femme et Homme

Extrait

The purpose of this study is to demonstrate the efficacy and safety of quetiapine fumarate (SEROQUEL) in the treatment of adolescent patients with schizophrenia and bipolar I disorder.


Critère d'inclusion

  • Schizophrenia ,Bipolar I Disorder


Liens